GlassScriptPhysician profile
Kionglee Jung
NPI 1184039968
$2,236.30
in general payments reported to CMS, 2019-2025
20 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $730 · 2022: $612 · 2023: $370 · 2024: $336 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $894.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $348.30 | 2021-2025 | Lybalvi, Aristada |
| Abbvie INC. | $336.63 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $332.18 | 2021-2025 | Caplyta |
| Sunovion Pharmaceuticals INC. | $294.08 | 2021-2022 | |
| Tris Pharma INC | $235.53 | 2021-2025 | Dyanavel Xr |
| Lundbeck LLC | $116.82 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $83.55 | 2021-2024 | Hyqvia, Trintellix |
| Janssen Pharmaceuticals, INC | $79.09 | 2021-2024 | Spravato |
| Corium, LLC | $73.09 | 2023-2025 | Azstarys |
| Otsuka America Pharmaceutical, INC. | $70.02 | 2021-2022 | |
| Eisai INC. | $48.65 | 2021 | |
| Vanda Pharmaceuticals INC. | $48.08 | 2021-2025 | Fanapt |
| Neos Therapeutics, LP | $34.15 | 2023 | Adzenys Xr-Odt |
| Noven Therapeutics, LLC | $30.90 | 2024 | Xelstrym |
| Adlon Therapeutics L.P. | $24.06 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $19.24 | 2022 | |
| Ironshore Pharmaceuticals INC. | $18.83 | 2023 | Jornay Pm |
| Avion Pharmaceuticals | $15.47 | 2023 | Methylphenidate Hydrochloride |
| Idorsia Pharmaceuticals US INC | $14.61 | 2023 | Quviviq |
| Jazz Pharmaceuticals INC. | $13.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kionglee Jung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.